EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Additive-manufacturing resins for dental restorations: indications and predicate pathways in FDA 510(k) clearances

Rigel Ramirez Fritze

SAP Dentistry · 2026-10-27 · 4 · 279

DOI: 10.62486/dent2026279 ↗
AbstractBibliografische Angaben

Abstract

Introduction: Additive manufacturing (3D printing) resins have expanded rapidly in restorative dentistry, and in the United States they reach the market through the FDA 510(k) pathway based on substantial equivalence to a predicate device. The number of such clearances and the pathways used have not been quantified. Methods: Cross-sectional analysis of the openFDA 510(k) database. All clearances with decision dates from 2018-01-01 to 2026-12-31 in the dental resin product codes for denture base (EBI), permanent tooth-shade (EBF) and temporary crown-and-bridge (EBG and POW) resins were included and classified as additively manufactured or conventionally fabricated using the FDA 510(k) summaries. Results: Of 249 clearances, 84 (33.70%) were additively manufactured resins, comprising 48 denture base, 19 permanent, 16 temporary and 1 long-term temporary resins. Additive clearances rose from 2 in 2018 to between 12 and 14 per year from 2020 onward. The Traditional pathway accounted for 74 clearances (88.10%), the Abbreviated pathway for 9 (10.70%) and the Special pathway for 1 (1.20%); 14 clearances (16.70%) used third-party review. A primary predicate was identifiable for 66 clearances (78.60%), most often NextDent Denture 3D+, Dentca Denture Base II and an early additive CAD/CAM system. Conclusions: Between 2018 and 2026, 3D-printable resins for dental restorations obtained 84 FDA 510(k) clearances, concentrated in denture bases and dominated by the Traditional predicate pathway, with a predicate cascade anchored in early additive-manufacturing devices.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →